Survivin-T34A: molecular mechanism and therapeutic potential
Jonathan R Aspe, Nathan R WallCenter for Health Disparities Research and Molecular Medicine, Division of Biochemistry and Microbiology, Department of Basic Sciences, Loma Linda University, Loma Linda, CA, USAAbstract: The inhibitor of apoptosis protein survivin's threonine 34 to alanine...
Main Authors: | Jonathan R Aspe, Nathan R Wall |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-12-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/survivin-t34a-molecular-mechanism-and-therapeutic-potential-a5833 |
Similar Items
-
Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant
by: Jonathan R. Aspe, et al.
Published: (2014-02-01) -
Survivin – biology and potential as a therapeutic target in oncology
by: Cheung CHA, et al.
Published: (2013-10-01) -
Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
by: Salma Khan, et al.
Published: (2012-01-01) -
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
by: Zakir Khan, et al.
Published: (2017-04-01) -
Survivin: A molecular biomarker in cancer
by: Praveen Kumar Jaiswal, et al.
Published: (2015-01-01)